$MGRX Cashflow Statement | Understand Stock

$MGRX

$0.25 -$0.00 (1.47%) Close

$MGRX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Issuance of common stock for services
Imputed interest expense
Other income
Options vested for stock-based compensation
Loss on sale of assets
Amortization on intangible assets
Amortization of intangible assets
Amortization of license agreement
Operating lease right of use asset
Inventory obsolescence
Loss from settlement
Loss from debt extinguishment – related parties
(Increase) decrease in operating assets:
Inventory
Due from related party
Impairment of license agreement
Prepaid expenses
Related Party
Nonrelated Party
Total prepaid expenses
Deposits
(Decrease) increase in operating liabilities:
Accounts payable and accrued liabilities
Accrued liabilities - related parties
Operating lease right-of-use liabilities
Payroll tax liabilities
Other liabilities
NET CASH USED IN OPERATING ACTIVITIES
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment
Sale of assets
NET CASH PROVIDED BY(USED IN) INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from borrowings on notes payable
Proceeds from borrowings on notes payable - related parties
Proceeds from sales of series B convertible preferred stock
Collection of subscriptions receivable
Repayment of borrowings on notes payable - related parties
Proceeds from exercise of warrants
NET CASH PROVIDED BY FINANCING ACTIVITIES
NET INCREASE IN CASH AND CASH EQUIVALENTS
End of period
CASH AND CASH EQUIVALENTS:
End of year
Beginning of period
Effects of currency translation on cash and cash equivalents
End of period
Supplemental schedule of non-cash investing and financing activities:
Right of use assets acquired under new operating leases
Issuance of common stock for license agreement
Issuance of common stock for patent acquisition
Issuance of Series C Convertible Preferred for patent acquisition
Issuance of common stock for Preferred B dividend
Issuance of common stock for payment of Preferred B dividend
Issuance of common stock for settlement of debt settlement
Issuance of common stock for settlement of note payable
Issuance of common stock for settlement of note payable - related parties
Issuance of common stock for conversion of Series B Convertible Preferred
Series C Convertible Preferred accrued dividends
Issuance of common stock for cashless warrant exercise

Comments